WXW PRODUCT CONCEPT
TIRZ 10 mg
WXW oral dissolving film concept shown for private B2B project reference.
Reference amount10 mgPack format10 oral films
ORAL DISSOLVING STRIPS · OEM / ODM · PRIVATE LABEL
Build your oral-strip brand with one manufacturing partner.
Start from a featured product direction or bring your own formula brief. We connect film development, samples, individual sachets, branded packaging, production and B2B project support.
Custom FormulaSample DevelopmentIndividual SachetsPrivate Label Packaging
B2B manufacturing projects only. Formula feasibility, ingredient status, labeling and destination-market requirements are confirmed before commercial production.
100MOQ from 100 units
30 stripsTypical sample test pack
≈ 10 daysTypical sample lead time
25–30 daysTypical bulk lead time after approval
FEATURED PRIVATE-LABEL DIRECTIONS
Three product directions, one flexible manufacturing platform.
Choose a product direction for the first discussion, or use it only as a visual reference while we develop a different formula, dose, flavor and pack for your brand.
WXW PRODUCT CONCEPT
SEMA 10 mg
WXW oral dissolving film concept shown for private B2B project reference.
Reference amount10 mgPack format10 oral films
WXW PRODUCT CONCEPT
RETA 10 mg
WXW oral dissolving film concept shown for private B2B project reference.
Reference amount10 mgPack format10 oral films
NEED A DIFFERENT FORMULA?Send your own ingredient brief or ask us to develop a new oral-strip direction.
Product concepts are shown for B2B project discussion. Final ingredient classification, formula, labeling, claims and market suitability must be reviewed for the intended destination market.
MOLECULE OVERVIEW
Understand the three molecule directions.
Mechanism reference for private B2B concept review. Regulatory status, approved route of administration, dose and commercial claims differ by molecule and market.
01
TIRZ
Tirzepatide
Dual GIP + GLP-1 receptor agonist
Tirzepatide activates both GIP and GLP-1 receptors. These pathways are involved in glucose-dependent insulin signaling, glucagon regulation, gastric emptying and appetite-related signaling.
02
SEMA
Semaglutide
GLP-1 receptor agonist
Semaglutide acts at the GLP-1 receptor. GLP-1 signaling is associated with glucose-dependent insulin secretion, reduced glucagon signaling, slower gastric emptying and appetite-related pathways.
03
RETA
Retatrutide
Triple GIP + GLP-1 + glucagon receptor agonist
Retatrutide is designed to activate GIP, GLP-1 and glucagon receptors in one molecule, combining three metabolic signaling pathways currently being studied in clinical development.
INSIDE SHENGMEI
A manufacturing platform behind your private-label brand.
Use one team for formulation review, pilot work, production, packaging and project documentation instead of coordinating separate suppliers.
17Years in operation
350Team members
13Production lines
30,000 m²Company-owned factory area
FROM BRIEF TO PRODUCTION
People, equipment and process connected around one project.
Move from formula discussion into sample review and commercial production with a clear project path and a manufacturing team that can discuss the physical film, packaging and documentation together.
01Formula & film feasibilityReview ingredients, loading, film base and sensory direction.
02Sample approvalEvaluate the prototype before commercial specifications are finalized.
03Finished branded packConfirm sachets, secondary packaging, artwork and order details.
PRIVATE LABEL / OEM / ODM
Build the product around your market and brand.
Start from one of the product concepts above or send a custom brief. The strip, sensory profile, pack format and supporting project documentation can then be developed around the commercial requirement.
Formula direction
Discuss active ingredients, target loading, serving direction and feasibility for the intended market.
Film engineering
Review film base, thickness, handling, mouthfeel, taste masking and appearance before scale-up.
Private-label packaging
Individual sachets with paper box, tin or stand-up pouch options depending on pack count and brand direction.
Project documentation
Product specification, batch COA and available quality records can be aligned with the finished goods supplied.
MANUFACTURING WORKFLOW
Four connected stages from R&D to release.
Click each stage to see the corresponding factory scene and understand how development moves toward commercial production.
01 · R&DFormula review & film development
FILM & PACKAGING ENGINEERING
See the physical process behind a finished oral strip.
From ingredient preparation and liquid mixing to coating, drying, slitting and sachet packaging, the manufacturing scenes below help buyers understand how the film moves through production.
ORAL STRIP FORMAT
A compact format with room for private-label differentiation.
Oral strips can be presented as individually sealed, pre-measured units with compact secondary packaging and brand-specific artwork.
01Pure Strip Format
Show the oral strip itself clearly to communicate a clean, modern dosage form.
02Individually Sealed
Single-strip sachets support hygiene, portability and easy sample presentation.
03Easy to Carry
Compact sachets fit naturally into daily routines, travel kits and on-the-go use cases.
04Simple Use Experience
Place the strip on the tongue for a straightforward user experience with no mixing required.
SAFETY & QUALITY REVIEW
Review the project before the bulk order.
Confirm the formula, approved sample, packaging direction and documentation needs before commercial production.
PUBLISHED FACTORY FILES
Ask for the records and testing scope applicable to your formula, finished product and target market.
Review quality & project documents ↗
Record the checks.
Ingredient & formula review
Review ingredients, target dose, strip weight and serving requirements for the intended market.
Sample approval
Approve the sample and agreed physical specification before bulk production begins.
Label & packaging review
Check artwork, pack count, sachet format, secondary packaging and proposed label wording.
Testing & project records
Confirm the testing scope and documentation required for the order and destination market.
CERTIFICATION & TESTING REQUIREMENTS
Your market.
Your project requirements.
Select the requirements you would like to discuss for your product and market.
Reference notes & additional requirements +
Project references only
These marks do not state certifications, awards or locations held by Shengmei.
Also discuss
HACCP, ISO 9001, Halal, Kosher and product-testing scope can be reviewed for your target market.
Regulatory responsibility
FDA facility registration does not approve products. Final claims, registration, labeling and import requirements should be confirmed for the target market.
Select any requirements you would like to discuss.
WHY WORK WITH SHENGMEI
A clearer manufacturing path for international B2B buyers.
Keep product development, physical film engineering, packaging and commercial communication connected with one factory team instead of splitting the project across unrelated suppliers.
Discuss formula, samples, packaging and production requirements with one project route.
Use sample development to review the physical strip and project direction before scale-up.
Individual sachets can be developed with paper box, tin or stand-up pouch secondary packaging.
Project documentation and shipment coordination can be discussed around the destination market and finished goods.
COMMERCIAL STARTING POINT
Clear starting terms for B2B buyers.
Final pricing depends on formula, strip weight, order quantity, packaging and destination market. These are standard starting points for initial project discussions.
MOQFrom 100 units
Low-MOQ starting point for initial B2B projects.
SamplesUSD 80 / 30 strips
Typical sample pack for formula testing.
Sample lead timeAbout 10 days
After formula direction is confirmed.
Bulk lead time25–30 days
After formula and artwork approval.
PackagingSachet + box / tin / pouch
Private-label artwork available.
Shelf lifeTypically 24 months
Subject to formula and stability confirmation.
FAQ
Questions B2B buyers usually ask first.
These answers describe the project workflow. Final commercial and regulatory details are confirmed against the specific formula and market.
They can be used as starting directions for a B2B manufacturing discussion. Formula feasibility, ingredient status, dose, artwork and destination-market requirements must be confirmed before commercial production.
Yes. Customization can be discussed around active ingredients, target strip weight, flavor and other product requirements, subject to formulation feasibility and destination-market requirements.
The starting MOQ is from 100 units. Final minimum quantity depends on the selected product direction, formula, packaging and project requirements.
Yes. A typical sample project is USD 80 for 30 strips, with an estimated sample lead time of about 10 days after the formula direction is confirmed.
Individual foil sachets are the primary pack. Secondary options can include paper boxes, tins and stand-up pouches, with private-label artwork.
Flavor and appearance options can be discussed during formulation development, depending on active ingredients, loading and film performance.
A typical bulk lead time is about 25–30 days after the final formula, specifications and artwork are approved.
Project documentation can include product specifications, batch COA and available quality/testing records. Third-party testing can be quoted separately when required.
B2B shipment support can be discussed for international projects. Import classification, registration and destination-market requirements should be confirmed for the specific project.
Private-label artwork and pack structure can be discussed for individual sachets and secondary packs. Final claims, labeling and market-specific wording remain subject to buyer and regulatory review.
START A B2B PROJECT
Tell us what you want to manufacture.
Choose a product direction, quantity and packaging route. The form is split into three short steps so buyers can finish the brief without a long one-page form.
100MOQ from units
3short form steps
2reply options